Biofourmis confirmed layoffs of about 120 employees globally, including 48 in the U.S.
SourcePublic company, workplace, funding, and market signals
Updated Jul 29, 2026
Biofourmis is a privately held digital health and care-delivery company that uses an AI-driven platform to support hospital-at-home, remote patient monitoring, and virtual care across the care continuum. The company merged with CopilotIQ in 2024; its life-sciences digital-trial business was later acquired by ActiGraph in January 2025.
Primary product
Biofourmis Care, an AI-driven in-home care and remote patient monitoring platform (with Biovitals as the underlying analytics platform)
Founded
2015
Headquarters
Needham, Massachusetts, United States
Team size
51-200
Industry
Hospitals and Health Care
Sub-industry
Digital health / virtual care / remote patient monitoring
Offices
Business model
Stage
Late Stage Venture
Total raised
$463.6M
Latest round
Series D Extension · Jul 2022
Latest amount
$20M
Oct 2024 · CopilotIQ
Jul 2022 · Intel Capital
Apr 2022 · General Atlantic
Sep 2020 · SoftBank Vision Fund 2
May 2019 · Sequoia India
Dec 2017 · Aviva; Openspace Capital
Aug 2017 · SpesNet; Eden Strategy Institute
Leadership
Chief Executive Officer
Chief Revenue Officer
Chief Medical Officer
Global Head, Engineering
Chief People Officer
Founders
Founder; former CEO
Mission-driven and fast-growing digital health culture centered on personalized care, complex chronic conditions, and outcome improvement. Public career pages and third-party profiles describe the team as globally distributed, committed, and focused on clinical and operational impact.
Compensation
Public salary signals are limited, but LinkedIn/job-site data suggests mid-market pay with a compensation rating around 3.6/5 and example postings/reported roles around USD 59.8k/year for Technical Support Analyst, USD 133.4k/year for Data Science Manager, and roughly SGD 42k/month for a Systems Engineer role.
Benefits
Pricing
Enterprise B2B contracts for healthcare organizations; public pricing is not disclosed and the company appears to use value-based / shared-savings style economics for some deployments.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$200M-$300M
Estimated monthly visits
902
Traffic estimate as of May 2026
Biofourmis confirmed layoffs of about 120 employees globally, including 48 in the U.S.
SourceThe company reportedly conducted another layoff round affecting about 45 staff in Singapore and at least 85 globally, and planned to vacate its Singapore office.
SourceFounder and CEO Kuldeep Singh Rajput stepped down; the company set up an Office of the CEO led by executives and overseen by Ben Wanamaker.
SourceActiGraph acquired Biofourmis Connect / the life-sciences business, reducing Biofourmis' scope to the care-delivery business.
SourceSTAT · Jan 2025
ActiGraph acquired Biofourmis' life sciences business, a deal that re-scoped Biofourmis toward care delivery and away from its digital-trial business.
Biofourmis · Jan 2025
Biofourmis announced a collaboration with AdventHealth to expand remote patient management and hospital-at-home care in Central Florida.
Business Wire · Nov 2024
Biofourmis announced a partnership with Lee Health to support RPM and launch a hospital-at-home program.
Biofourmis · Oct 2024
Biofourmis and CopilotIQ announced a strategic merger to create an AI-driven in-home care platform spanning pre-surgery, acute, post-acute, and chronic care.
MobiHealthNews · Aug 2023
Founder and CEO Kuldeep Singh Rajput stepped down shortly after the company announced global layoffs.
1 job at Biofourmis